Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
about
Long-term α1B-adrenergic receptor activation shortens lifespan, while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence.Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transportAnti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1- yloxy)propan-2-ol may be a promising anticancer drug.Synthesis and cytotoxic activity evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol as a potential anticancer drug.Reduction of prostate cancer incidence by naftopidil, an α1 -adrenoceptor antagonist and transforming growth factor-β signaling inhibitor.Antitumor action of α(1)-adrenoceptor blockers on human bladder, prostate and renal cancer cells.Identification of a new pharmacological activity of the phenylpiperazine derivative naftopidil: tubulin-binding drug.5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.Synthesis and Antitumor Activity of Novel Arylpiperazine Derivatives Containing the Saccharin Moiety.Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro.Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study.Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells.Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents
P2860
Q34116137-34713D69-00E5-4016-A700-1D9A7AA025D8Q34166212-A10AB70F-0EB9-4012-BC4E-339ACBDCFE4FQ34575446-DBF207B0-F2C7-4FFA-B3D4-78F64D68DE34Q37365172-40251FAB-5C5E-41E6-9990-D5DBE1965206Q38795167-7BE10642-29E2-4D57-B075-5374330BEA07Q38926248-2C2D7743-C987-4D41-984A-8C9DEDCCE578Q38966404-4ACDFF3D-7506-4C49-BBD3-5B05B7E94666Q39132093-0F5C0FA5-1E6F-4D36-A73C-365717499492Q39163721-1067CAEF-4F01-4126-B771-4936B839EE2EQ39272532-E813D67C-C305-4E3E-8868-40BADEF037A2Q41905331-4E8B9A90-5B09-4EB3-9E98-559C88D914B1Q44968836-DEF78E13-54B8-459E-A8F0-57A40D05BFC1Q47646594-160AC954-53DE-4DEF-A8D4-FE7137C1384AQ48371276-EC7AFBDF-529F-4550-A4E2-9A7890C451A9Q49631969-5EFD4CDE-8CD6-427C-8701-05B906E4A7B7Q53281714-478E5AAA-0383-4D06-B56F-CB1C56A96CE7Q53749396-D471107A-ABEA-42BC-9BD7-7FE48B39A181Q58700153-045DC646-6F1B-4E8B-B1CE-8A4C8B5222C5
P2860
Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Naftopidil, a selective alpha- ...... cells by G1 cell cycle arrest.
@en
type
label
Naftopidil, a selective alpha- ...... cells by G1 cell cycle arrest.
@en
prefLabel
Naftopidil, a selective alpha- ...... cells by G1 cell cycle arrest.
@en
P2093
P2860
P356
P1476
Naftopidil, a selective alpha- ...... cells by G1 cell cycle arrest.
@en
P2093
Hideki Kanda
Kenichiro Ishii
Kiminobu Arima
Masahiro Kanai
Tetsuya Imamura
Yoshiki Sugimura
Yuji Ogura
P2860
P304
P356
10.1002/IJC.23095
P577
2008-01-01T00:00:00Z